Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S)
Cells · 2025
DOI: 10.3390/cells14120896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Natalia A Muraleva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Federal Research Center Institute of Cytology and Genetics SB RAS, 10 Pr. Akad. Lavrentieva, Novosibirsk 630090, Russia. Hauptthemen laut MEDLINE: Macular Degeneration, Retina, MAP Kinase Signaling System, Aging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Age-related macular degeneration (AMD) is the leading cause of irreversible visual impairment worldwide. AMD development is associated with inflammation, oxidative stress, and a progressive proteostasis imbalance, in whose regulation, c-Jun N-terminal kinases (JNKs) play a crucial role. JNK inhibition is being discussed as a new way to prevent and treat AMD, but there are no data on JNK signaling in the retina and its changes with age and with AMD development. Here, for the first time, we assessed JNK-signaling activity in the retina and did not detect its age-related changes in healthy Wistar rats. By contrast, manifestation and progression of the AMD-like pathology in OXYS rats occurred simultaneously with JNK pathway activation. We also confirmed that selective JNK3 inhibitor 11H-indeno[1,2-b]quinoxalin-11-one oxime sodium salt (IQ-1S) can suppress neurodegenerative changes in the OXYS rat retina. Its effects were prevention of the destructive changes in retinal synapses and the suppression of the JNK signaling pathway activity during active progression of AMD signs in OXYS rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Federal Research Center Institute of Cytology and Genetics SB RAS, 10 Pr. Akad. Lavrentieva, Novosibirsk 630090, Russia.
- Department of Histology, Embryology and Cytology, Siberian State Medical University, Tomsk 634055, Russia.
- Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk NRMC, 3 Lenin Ave., Tomsk 634028, Russia.
- Radoiphysical Faculty, National Research Tomsk State University, Tomsk 634050, Russia.
- Kizhner Research Center, Tomsk Polytechnic University, 30 Lenin Ave, Tomsk 634050, Russia.
ORCID-Profile: Natalia A Muraleva, Anna A Zhdankina, Mark B Plotnikov, Andrei I Khlebnikov, Nataliya G Kolosova
Förderung
- Russian Science Foundation
Zitieren
APA
Muraleva, N. A., Tikhonov, D. I., Zhdankina, A. A., Plotnikov, M. B., Khlebnikov, A. I., Logvinov, S. V., & Kolosova, N. G. (2025). Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S). Cells. https://doi.org/10.3390/cells14120896
Vancouver
Muraleva NA, Tikhonov DI, Zhdankina AA, Plotnikov MB, Khlebnikov AI, Logvinov SV, et al. Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S). Cells. 2025. doi:10.3390/cells14120896
BibTeX
@article{Muraleva2025,
author = {Muraleva, Natalia A and Tikhonov, Dmitry I and Zhdankina, Anna A and Plotnikov, Mark B and Khlebnikov, Andrei I and Logvinov, Sergey V and Kolosova, Nataliya G},
title = {Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S)},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14120896}
}
EUVIMED